Atlas Trials

COVID-19 Antibody Responses in Cystic Fibrosis

Clinical trial NCT04992234 · COMPLETED

Trial details

NCT number
NCT04992234
Sponsor
Vastra Gotaland Region
Status
COMPLETED
Study type
OBSERVATIONAL
Cystic FibrosisCovid19
Start date
2021-08-31
Primary completion
2024-07-22
Enrollment
113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.